-
2022.04.21
J-Pharma Announces FDA Orphan Drug Designation for JPH203 for the Treatment of Biliary Tract Cancer
-
What's new
- Life Science Review Magazine named J-Pharma as a Top 10 Bio Tech Startup in APAC 2022 2022/05/19
- J-Pharma Announces FDA Orphan Drug Designation for JPH203 for the Treatment of Biliary Tract Cancer 2022/04/21
- J-Pharma to Present at The 40th Annual J.P. Morgan Healthcare Conference 2022/01/05
- Participation in the Startup City Acceleration Program 2021/11/22
- J-Pharma Raises 600 Million JPY from JIC Venture Growth Investments(VGI) 2021/07/30
-
Monthly